cureab is a swiss based biotech company that was founded in 2012. -cureab is focussed on research in inflammation and oncology. -cureab develops therapeutic antibodies from target identification to clinical testing. -two monoclonal antibodies are in late stage pre-clinical development. -cureab welcomes new partnerships with academia and industry.